510(k) device
Quantia IgE
Biokit, S.A. · Ige, Antigen, Antiserum, Control (DGC, Class II) · First FDA decision Aug 16, 2005, newest Feb 21, 2023Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Quantia IgE"
MAUDE reports
0
Brand "Quantia IgE", since 2015
PubMed studies
0
Mentioning "Quantia IgE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Quantia IgE
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Quantia IgE510(k)
K214068 · Decided Feb 21, 2023 · 421 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
- QUANTIA IGE510(k)
K050493 · Decided Aug 16, 2005 · 169 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Quantia IgE", any status and sponsor, newest update first.
No registered device study names "Quantia IgE".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Quantia IgE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DGC
6 reports: 6 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Quantia IgE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DGC.
- ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control StripPhadia AB · 510(k) 2016
- Kenota 1 Total IgEKenota, Inc. · 510(k) 2024
- Total Immunoglobulin E (IgE)Beckman Coulter, Inc. · 510(k) 2022
- ADVIA Centaur Total IgE (tIgE)Siemens Healthcare Diagnostics, Inc. · 510(k) 2020
- Dimension Vista Ige Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093CKamiya Biomedical Co. · 510(k) 2004
- LacrytestAdiatec SA · 510(k) 2004
- Immunetech Total Ige SystemImmunetech Corporation · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.